Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001723643-25-000013·LAVA Therapeutics NV
Schedule 13G ownership disclosure
LAVA THERAPEUTICS NV
Common shares, par value (euro) 0.12 per share · CUSIP: N51517105
Event date: 2025-09-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Shay Capital LLC
Shares: 2,596,403.00 · Class: 9.9%
- Shay Capital Holdings LLC
Shares: 2,596,403.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001723643-25-000013
- Form type
- SCHEDULE 13G
- Filer
- LAVA Therapeutics NV
- CIK
- CIK 1840748
- Filed
- Sep 26, 2025
- Reporting period
- Sep 19, 2025
- Description
- Schedule 13G beneficial ownership